Zobrazeno 1 - 10
of 394
pro vyhledávání: '"Eelko, Hak"'
Publikováno v:
Health and Quality of Life Outcomes, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background We aimed to investigate the longitudinal impact of COVID-19 and the effects of clinical and psychosocial factors, accounting for post-COVID conditions (PCC), on the mental and physical aspect of health-related quality of life (HRQ
Externí odkaz:
https://doaj.org/article/80dff07eb1484480a2dbb643f7809b4c
Autor:
Sumaira Mubarik, Shafaq Naeem, Hui Shen, Rabia Mubarak, Lisha Luo, Syeda Rija Hussain, Eelko Hak, Chuanhua Yu, Xiaoxue Liu
Publikováno v:
JMIR Public Health and Surveillance, Vol 10, Pp e57840-e57840 (2024)
Abstract BackgroundCardiovascular diseases (CVDs) and neoplasms are leading causes of mortality worldwide. ObjectiveThis study aims to provide a comprehensive analysis of the mortality burden and disability-adjusted life years (DALYs) attributable
Externí odkaz:
https://doaj.org/article/a8e86ebbe37145528a8c99e066d48ab9
Autor:
Xuechun Li, Maarten J. Bijlsma, Stijn de Vos, Jens H. J. Bos, Sumaira Mubarik, Catharina C. M. Schuiling-Veninga, Eelko Hak
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionAntihypertensive drugs are used preventatively to lower the risk of cardiovascular disease events. Comparative effectiveness studies on angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), beta-blocke
Externí odkaz:
https://doaj.org/article/ebb980d0613a4513a26bd275034428e4
Autor:
Frank Klont, Marieke A.J. Hof, Fleur B. Nijdam, Daan J. Touw, Stephan J.L. Bakker, Gérard Hopfgartner, Jos G.W. Kosterink, Eelko Hak
Publikováno v:
Pharmacological Research, Vol 204, Iss , Pp 107191- (2024)
Externí odkaz:
https://doaj.org/article/aff49a3d4b9948b58c6e094a3e7a30d0
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 1, Pp 99-108 (2023)
Abstract Objective Drug non-adherence in primary preventive cardiovascular therapy is one of the most important modifiable drivers of cardiovascular events. The effect of deductibles in healthcare cost-sharing plans (the amount that has to be paid fo
Externí odkaz:
https://doaj.org/article/d75bcff5d72b458aa117e33c4271f211
Autor:
Sofa D. Alfian, Qisty A. Khoiry, Mochammad Andhika A. Pratama, Ivan S. Pradipta, Susi A. Kristina, Elida Zairina, Eelko Hak, Rizky Abdulah
Publikováno v:
BMC Medical Education, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Introduction The coronavirus disease 2019 (COVID-19) pandemic accelerated the provision of telepharmacy services. However, little is known about the knowledge, perception, and willingness of pharmacy students as future key players in telepha
Externí odkaz:
https://doaj.org/article/8a239393aded4cab990d184573232730
Autor:
Sumaira Mubarik, Saima Shakil Malik, Zhang Yanran, Eelko Hak, Nawsherwan, Fang Wang, Chuanhua Yu
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Numerous studies over the past four decades have revealed that breast cancer screening (BCS) significantly reduces breast cancer (BC) mortality. However, in BRICS-plus countries, the association between BCS and BC case fatality an
Externí odkaz:
https://doaj.org/article/3484a500b2f842429395df2009f1839a
Publikováno v:
Journal of Diabetes Research, Vol 2024 (2024)
Aims. To investigate the effect of serotonin transporter (5-HTT) polymorphisms on change in HbA1c levels six months after metformin initiation in type 2 diabetes patients. Materials and Methods. Participants of PROVALID (PROspective cohort study in p
Externí odkaz:
https://doaj.org/article/d9b8afe506f24094b9bfb4bae02b6973
Autor:
Anne Eudes Jean Baptiste, Jurjen Van der Schans, Samuel Bawa, Balcha Masresha, John Wagai, Joseph Oteri, Boubacar Dieng, Margaret Soyemi, Rufus Eshuchi, Yared G. Yehualashet, Oluwole Afolabi, Fiona Braka, André Bita, Eelko Hak
Publikováno v:
Health Economics Review, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Background Effective integration, one of the seven strategic priorities of the Immunization Agenda 2030, can contribute to increasing vaccination coverage and efficiency. The objective of the study is to measure and compare input costs of
Externí odkaz:
https://doaj.org/article/ba96fb33afc64cb7b4fe579eeebdf5ad
Autor:
Judith M Vonk, Eelko Hak, Katrien Oude Rengerink, Hubert G M Niesters, Debbie van Baarle, Maarten J Bijlsma, Guiling Zhou, Stefan Verweij, Stijn de Vos, Anna Maria Gerdina Pasmooij, Peter Mol
Publikováno v:
BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)
Objective Current evidence on the effectiveness of SARS-CoV-2 prophylaxis is inconclusive. We aimed to systematically evaluate published studies on repurposed drugs for the prevention of laboratory-confirmed SARS-CoV-2 infection and/or COVID-19 among
Externí odkaz:
https://doaj.org/article/21cd98ae02b5486ea9d64750c16b16f3